November 14th, 2016 by aveciapharma
MILFORD, MA – Nitto Avecia Inc. (Avecia) today released its progress in expanding the company’s analytical development and oligonucleotide manufacturing capacities. The announcement signals the continuation of Avecia’s robust growth strategy to significantly increase its oligonucleotide...
Read Full Story »
Tags: announcements, testing and development, oligonucleotide
Posted in: Press Release
October 11th, 2016 by aveciapharma
MILFORD, MA – Nitto Denko Avecia, Inc. (Avecia), today announced it has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services (Irvine) and Avrio Biopharmaceuticals (Avrio), both located in Irvine, CA. Irvine is a leading analytical development services...
Read Full Story »
Tags: GMP environment, announcements, oligonucleotide
Posted in: Company News, Press Release
March 22nd, 2016 by aveciapharma
Precision in microbiological data is critical. Nitto Avecia Pharma Services offers extensive testing services via our highly experienced microbiology team. Avecia offers a broad range of compliant, high quality microbiological services. Tests are performed according to official compendial, or industry...
Read Full Story »
Tags: biologics, testing and development
Posted in: Services